Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.8% in the afternoon session after a major competitor, Novo Nordisk, announced that its experimental obesity drug failed to show it ...

Learn how to crochet a cute cake box and lily pad coasters with this easy, beginner-friendly tutorial. #CrochetTutorial #CakeBoxCoasters #BeginnerCrochet Trump slams energy deal between California and ...

Pharmaceutical giant Eli Lilly (NYSE: LLY) has been the winner in the massive GLP-1 drug category, the class of medications that have proven extremely effective in lowering blood sugar levels and ...

Flush with cash from its obesity/diabetes dual blockbuster tirzepatide, Eli Lilly signaled earlier this month that it intended to invest some of that money into new deals to strengthen its pipelines ...

Eli Lilly's GLP-1 drugs have seen strong demand, which has investors excited about the future. The company knows that its GLP-1 success won't last forever and is exploring additional paths. Eli Lilly ...

OUR MARY SALADNA SHOWS US HOW HUNDREDS WILL FILL SAINT ANNE’S CATHOLIC CHURCH TOMORROW MORNING. TO PRAY FOR THE SOUL OF A CURCIO GUS SANFILIPPO. THE EMOTIONAL FAREWELL GOT UNDERWAY TONIGHT. THEY ...

Eli Lilly will buy therapy developer Orna Therapeutics for up to US$2.4 billion in cash, the companies said on Monday. This marks the latest in the string of deals the U.S. drugmaker has signed over ...

(RTTNews) - Eli Lilly and Co. (LLY) and Orna Therapeutics, Inc., a biotechnology company, announced Monday that they have entry into a definitive agreement for Lilly to acquire Orna for up to $2.4 ...

Feb 9 (Reuters) - Eli ‌Lilly will buy Orna Therapeutics for ‌up to $2.4 billion in cash, gaining access to a technology that allows patients' own cells to generate therapies inside the body, without ...

Eli Lilly is heading back to its regular Chinese collaborator Innovent Biologics with $350 million in upfront cash to collaborate on new meds for patients with cancer or immune disorders. The ...